Last reviewed · How we verify

NCT03628729

Investigation of the Incidence of Caries in Pits and Fissures Sealed With Bioactive Sealant

Status unknown NA Last updated 15 August 2018
What this trial tests

NA trial testing Embrace™ WetBond™ Pit & Fissure Sealant in Pit and Fissure Caries in 80 participants. Status unknown.

Timeline
1 August 2018
Primary endpoint
1 January 2019
1 January 2019

Quick facts

Lead sponsorCairo University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposeprevention
Enrollment80
Start date1 August 2018
Primary completion1 January 2019
Estimated completion1 January 2019

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 16 to 25, any sex, with Pit and Fissure Caries. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

This study will be conducted to investigate the incidence of caries in pits and fissures sealed with a bioactive sealant compared to a fluoride releasing resin based pits and fissures sealant in preventive treatment procedures in adult population over a six months period.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03628729.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing